More than 12% of physicians do not have managed care contracts, but the break down varies by situation
In 2008, 87% of physicians had managed care contracts, according to the Center for Studying Health System Change (HSC) 2008 Health Tracking Physician Survey, funded by the Robert Wood Johnson Foundation. Compared with physicians with one or more managed care contracts, physicians without managed care contracts were more likely to have practiced for more than 20 years, work fewer than 40 hours per week, lack board certification, work in solo or two-physician practices, live in the western United States and report practicing in a "non-competitive" environment.
"Physicians still don't like managed care, but they continue to lose the ability to do anything about it," Heller says.
On a positive note, Heller tells Managed Healthcare Executive: "Managed care companies have become much more physician-friendly and physician-oriented. They have come to realize that it is cooperation and not competition that works best for both parties."
DOLLAR-DRIVEN DECISIONS
Physicians' clinical decisions determine how up to 90 cents of every healthcare dollar is spent, according to Cassil.
Paul Keckley, executive director, Deloitte Center for Health Solutions, believes that much attention is being paid to the emergent role of consumers as active participants in clinical decisions, and physicians remain the dominant influence on health expenditures and drive most costs directly, however, "the 90% is a bit high."
The managed care community needs to better understand physician concerns, according to Heller.
"Involve community physicians in the managed care plan's policy and operational matters," he says. "Participate in physician training opportunities at medical schools and hospitals; hire locally, and train and support local physician leadership."
Keckley says plans should be candid with physicians, using reliable facts and hard data to influence behavior.
"Physicians are generally frustrated and fearful about the future," he says. "They want to be respected. They want to be seen as professionals and be free of intrusion by managed care. That said, they respond to tools, not rules, and the most meaningful tools are those that help them make better judgments about patient care."
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with Ceci Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
The Departments of Health and Human Services (HHS), Labor, and the Treasury, released final rules on short-term, limited-duration insurance (STLDI) and independent, non-coordinated excepted benefits coverage, addressing issues related to the low-quality insurance, or "junk insurance" plans.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and Ceci Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 28th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More